Bacterial vaginosis: A state of microbial dysbiosis

Peebles, 2019, High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis, Sex Transm Dis, 46, 304, 10.1097/OLQ.0000000000000972 Bitew, 2021, The prevalence, antibiotic resistance pattern, and associated factors of Bacterial vaginosis among women of the reproductive age group from Felege, Hiwot Referral Hospital, Ethiopia, Infect Drug Resist, 14, 2685, 10.2147/IDR.S305329 Coleman, 2018, Molecular diagnosis of bacterial vaginosis: an update, J Clin Microbiol, 56, 10.1128/JCM.00342-18 Döderlein, 1892 Donders, 2007, Definition and classification of abnormal vaginal flora, Best Pract Res Clin Obstet Gynaecol, 21, 355, 10.1016/j.bpobgyn.2007.01.002 Leopold, 1953, Heretofore undescribed organism isolated from the genitourinary system, US Armed Forces Med, 4, 263 Gardner, 1955, Haemophilus vaginals vaginitis: a newly defined specific infection previously classified “non-specific” vaginitis, Am J Obstet Gynecol, 69, 962, 10.1016/0002-9378(55)90095-8 Bautista, 2016, Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections, Mil Med Res, 3, 4 Greenwood, 1980, Transfer of Haemophilus vaginalis gardner and Dukes to a new genus, Gardnerella: G. vaginalis (gardner and Dukes), Int J Syst Bacteriol, 30, 170, 10.1099/00207713-30-1-170 Fredricks, 2005, Molecular identification of bacteria associated with bacterial vaginosis, N Engl J Med, 353, 1899, 10.1056/NEJMoa043802 Chavoustie, 2017, Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers, Int J Gynaecol Obstet, 137, 107, 10.1002/ijgo.12114 Amsel, 1983, Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations, Am J Med, 74, 14, 10.1016/0002-9343(83)91112-9 Palmeira-de-Oliveira, 2015, New strategies for local treatment of vaginal infections, Adv Drug Deliv Rev, 92, 105, 10.1016/j.addr.2015.06.008 Bradshaw, 2015, Making inroads into improving treatment of bacterial vaginosis – striving for long-term cure, BMC Infect Dis, 15, 292, 10.1186/s12879-015-1027-4 Vodstrcil, 2021, Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment, BMC Med, 19, 194, 10.1186/s12916-021-02077-3 Jones, 2019, Bacterial vaginosis: a review of treatment, recurrence, and disparities, J Nurse Pract, 15, 420 Verstraelen, 2019, The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment: 2018 update, Curr Opin Infect Dis, 32, 38, 10.1097/QCO.0000000000000516 Nelson, 2015, Vaginal biogenic amines: biomarkers of bacterial vaginosis or precursors to vaginal dysbiosis?, Front Physiol, 6, 253, 10.3389/fphys.2015.00253 Coudray, 2020, Bacterial vaginosis: a synopsis of literature, Eur J Obstet Gynecol Reprod Biol, 245, 143, 10.1016/j.ejogrb.2019.12.035 Koumans, 2007, The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive health, Sex Transm Dis, 34, 864, 10.1097/OLQ.0b013e318074e565 Morris, 2001, Bacterial vaginosis: a public health review, BJOG, 108, 439 Joseph, 2021, Finding a balance in the vaginal microbiome: how do we treat and prevent the occurrence of bacterial vaginosis?, Antibiotics (Basel), 10, 719, 10.3390/antibiotics10060719 Hay, 2017, Bacterial vaginosis. F1000Res, 6, 1761, 10.12688/f1000research.11417.1 Pekmezovic, 2019, Host-pathogen interactions during female genital tract infections, Trends Microbiol, 27, 982, 10.1016/j.tim.2019.07.006 Linhares, 2011, Contemporary perspectives on vaginal pH and lactobacilli, Am J Obstet Gynecol, 204, 120.e1, 10.1016/j.ajog.2010.07.010 Chen, 2021, The female vaginal microbiome in health and bacterial vaginosis, Front Cell Infect Microbiol, 11 Vásquez, 2002, Vaginal lactobacillus flora of healthy Swedish women, J Clin Microbiol, 40, 2746, 10.1128/JCM.40.8.2746-2749.2002 Spiegel, 1991, Bacterial vaginosis, Clin Microbiol Rev, 4, 485, 10.1128/CMR.4.4.485 Redelinghuys, 2020, Bacterial vaginosis: current diagnostic avenues and future opportunities, Front Cell Infect Microbiol, 10, 354, 10.3389/fcimb.2020.00354 Smith, 2017, The vaginal microbiota, host defense, and reproductive physiology, J Physiol, 595, 451, 10.1113/JP271694 Cauci, 2002, Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women, J Clin Microbiol, 40, 2147, 10.1128/JCM.40.6.2147-2152.2002 Danielsson, 2011, The genital econiche: focus on microbiota and bacterial vaginosis, Ann N Y Acad Sci, 1230, 48, 10.1111/j.1749-6632.2011.06041.x Ma, 2012, Vaginal microbiome: rethinking health and disease, Annu Rev Microbiol, 66, 371, 10.1146/annurev-micro-092611-150157 Gliniewicz, 2019, Comparison of the vaginal microbiomes of premenopausal and postmenopausal women, Front Microbiol, 10, 193, 10.3389/fmicb.2019.00193 Mendling, 2016, Vaginal microbiota, 83, 10.1007/978-3-319-31248-4_6 de Vos, 2012, Human microbiota in health and disease, Self Care, 3, 1 Gajer, 2012, Temporal dynamics of the human vaginal microbiota, Sci Transl Med, 4, 132ra52, 10.1126/scitranslmed.3003605 Hyman, 2005, Microbes on the human vaginal epithelium, Proc Natl Acad Sci U S A, 102, 7952, 10.1073/pnas.0503236102 Zhou, 2007, Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women, ISME J, 1, 121, 10.1038/ismej.2007.12 Zhou, 2010, The vaginal bacterial communities of Japanese women resemble those of women in other racial groups, FEMS Immunol Med Microbiol, 58, 169, 10.1111/j.1574-695X.2009.00618.x Ravel, 2011, Vaginal microbiome of reproductive-age women, Proc Natl Acad Sci U S A, 108, 4680, 10.1073/pnas.1002611107 Aagaard, 2012, A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy, PLoS One, 7, 10.1371/journal.pone.0036466 Fettweis, 2014, Differences in vaginal microbiome in African American women versus women of European ancestry, Microbiology (Research), 160, 2272 Mehta, 2020, Vaginal microbiome of pregnant Indian women: insights into the genome of dominant Lactobacillus species, Microb Ecol, 80, 487, 10.1007/s00248-020-01501-0 Verstraelen, 2009, Gene polymorphisms of Toll-like and related recognition receptors in relation to the vaginal carriage of Gardenerella vaginalis and Atopobium vaginae, J Reprod Immunol, 79, 163, 10.1016/j.jri.2008.10.006 Mitchell, 2014, Bacterial vaginosis and the cervicovaginal immune response, Am J Reprod Immunol, 71, 555, 10.1111/aji.12264 Demirezen, 2003, Cytolytic vaginosis: examination of 2947 vaginal smears, Cent Eur J Publ Health, 11, 23 Kumar, 2011, Pathogen recognition by the innate immune system, Int Rev Immunol, 30, 16, 10.3109/08830185.2010.529976 Medzhitov, 2008, Origin and physiological roles of inflammation, Nature, 454, 428, 10.1038/nature07201 St John, 2007, Bacterial vaginosis and host immunity, Curr HIV AIDS Rep, 4, 22, 10.1007/s11904-007-0004-y Edwards, 2019, The cervicovaginal microbiota-Host interaction modulates Chlamydia trachomatis infection, mBio, 10, 10.1128/mBio.01548-19 Chen, 2017, The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases, Nat Commun, 8, 875, 10.1038/s41467-017-00901-0 Witkin, 2013, Influence of vaginal bacteria and D- and L- Lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections, mBio, 4, 10.1128/mBio.00460-13 Łaniewski, 2019, Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis, Sci Rep, 9, 7333, 10.1038/s41598-019-43849-5 Lennard, 2018, Microbial composition predicts genital tract inflammation and persistent bacterial vaginosis in South African adolescent females, Infect Immun, 86, e00410, 10.1128/IAI.00410-17 Witkin, 2013, Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections, mBio, 4, 10.1128/mBio.00460-13 Kalia, 2019, Immunopathology of recurrent vulvovaginal infections: new aspects and research directions, Front Immunol, 10, 2034, 10.3389/fimmu.2019.02034 Al-Harthi, 1998, A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the κB enhancer, J Infect Dis, 178, 1343, 10.1086/314444 Anahtar, 2015, Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract, Immunity, 42, 965, 10.1016/j.immuni.2015.04.019 Pellis, 2005, Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina, Clin Exp Immunol, 139, 120, 10.1111/j.1365-2249.2005.02660.x Eskan, 2008, Interleukin-1β modulates proinflammatory cytokine production in human epithelial cells, Infect Immun, 76, 2080, 10.1128/IAI.01428-07 Zhang, 2022, The interplay between microbiota, metabolites, immunity during BV, Med Microecol, 11, 10.1016/j.medmic.2021.100049 Cauci, 2003, Interrelationships of interleukin-8 with interleukin-1β and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women, Mol Hum Reprod, 9, 53, 10.1093/molehr/gag003 Giraldo, 2012, Identification of immune cells by flow cytometry in vaginal lavages from women with vulvovaginitis and normal microflora, Am J Reprod Immunol, 67, 198, 10.1111/j.1600-0897.2011.01093.x Wiesenfeld, 2002, Association between elevated neutrophil defensin levels and endometritis, J Infect Dis, 186, 792, 10.1086/342417 LeBlanc, 2006, Role for dendritic cells in immunoregulation during experimental vaginal candidiasis, Infect Immun, 74, 3213, 10.1128/IAI.01824-05 Chacra, 2022, Bacterial vaginosis: what do we currently know?, Front Cell Infect Microbiol, 18 Muzny, 2020, Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis, Curr Opin Infect Dis, 33, 59, 10.1097/QCO.0000000000000620 Aldunate, 2015, Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis, Front Physiol, 6, 164, 10.3389/fphys.2015.00164 Cauci, 2002, Correlation of local interleukin-1beta levels with specific IgA response against Gardnerella vaginalis cytolysin in women with bacterial vaginosis, Am J Reprod Immunol, 47, 257, 10.1034/j.1600-0897.2002.01096.x Muzny, 2019, An updated conceptual model on the pathogenesis of bacterial vaginosis, J Infect Dis, 220, 1399, 10.1093/infdis/jiz342 Patterson, 2010, Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes, Microbiology, 156, 392, 10.1099/mic.0.034280-0 Schwebke, 2014, Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model, J Infect Dis, 210, 338, 10.1093/infdis/jiu089 Muzny, 2018, Identification of key bacteria involved in the induction of incident bacterial vaginosis: a prospective study, J Infect Dis, 218, 966 Janulaitiene, 2017, Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis, BMC Infect Dis, 17, 394, 10.1186/s12879-017-2501-y Vaneechoutte, 2019, Emended description of Gardnerella vaginalis and description of Gardnerella leopoldii sp. nov., Gardnerella piotii sp. nov. and Gardnerella swidsinskii sp. nov., with delineation of 13 genomic species within the genus Gardnerella, Int J Syst Evol Microbiol, 69, 679, 10.1099/ijsem.0.003200 Castro, 2015, Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates, Sci Rep, 5, 10.1038/srep11640 Flemming, 2016, Biofilms: an emergent form of bacterial life, Nat Rev Microbiol, 14, 563, 10.1038/nrmicro.2016.94 Machado, 2015, Influence of biofilm formation by Gardnerella vaginalis and other anaerobes on bacterial vaginosis, J Infect Dis, 212, 1856, 10.1093/infdis/jiv338 Verderosa, 2019, Bacterial biofilm eradication agents: a current review, Front Chem, 7, 824, 10.3389/fchem.2019.00824 Pena, 2019, Relationship between quorum sensing and secretion systems, Front Microbiol, 10, 1100, 10.3389/fmicb.2019.01100 Castro, 2017, Comparative transcriptomic analysis of Gardnerella vaginalis biofilms vs. planktonic cultures using RNA-seq, npj Biofilms Microbiomes, 3, 3, 10.1038/s41522-017-0012-7 Patterson, 2007, Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid, Am J Obstet Gynecol, 197, 170.e1, 10.1016/j.ajog.2007.02.027 Machado, 2013, Interactions between Lactobacillus crispatus and bacterial vaginosis (BV)-associated bacterial species in initial attachment and biofilm formation, Int J Mol Sci, 14, 12004, 10.3390/ijms140612004 Thurlow, 2011, Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo, J Immunol, 186, 6585, 10.4049/jimmunol.1002794 Swidsinski, 2011, Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment, FEMS Immunol Med Microbiol, 61, 41, 10.1111/j.1574-695X.2010.00743.x Jung, 2017, Etiology of bacterial vaginosis and polymicrobial biofilm formation, Crit Rev Microbiol, 43, 651, 10.1080/1040841X.2017.1291579 Pybus, 1997, Evidence for a commensal, symbiotic relationship between Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial vaginosis, J Infect Dis, 175, 406, 10.1093/infdis/175.2.406 Chen, 1979, Amine content of vaginal fluid from untreated and treated patients with nonspecific vaginitis, J Clin Invest, 63, 828, 10.1172/JCI109382 Gilbert, 2019, Gardnerella vaginalis and Prevotella bivia trigger distinct and overlapping phenotypes in a mouse model of bacterial vaginosis, J Infect Dis, 220, 1099, 10.1093/infdis/jiy704 Rickard, 2003, Bacterial coaggregation: an integral process in the development of multi-species biofilm, Trends Microbiol, 11, 94, 10.1016/S0966-842X(02)00034-3 Peters, 2012, Polymicrobial interactions: impact on pathogenesis and human disease, Clin Microbiol Rev, 25, 193, 10.1128/CMR.00013-11 Castro, 2019, Unveiling the role of Gardnerella vaginalis in polymicrobial bacterial vaginosis biofilms: the impact of other vaginal pathogens living as neighbors, ISME J, 13, 1306, 10.1038/s41396-018-0337-0 Gelber, 2008, Functional and phylogenetic characterization of vaginolysin, the human-specific cytolysin from Gardnerella vaginalis, J Bacteriol, 190, 3896, 10.1128/JB.01965-07 Rottini, 1990, Identification and partial characterization of a cytolytic toxin produced by Gardnerella vaginalis, Infect Immun, 77, 3751, 10.1128/iai.58.11.3751-3758.1990 Garcia, 2019, Interaction of Gardnerella vaginalis and vaginolysin with the apical versus basolateral face of a three-dimensional model of vaginal epithelium, Infect Immun, 87, 10.1128/IAI.00646-18 Hardy, 2017, Bacterial biofilms in the vagina, Res Microbiol, 168, 865, 10.1016/j.resmic.2017.02.001 Pleckaityte, 2012, Genetic and biochemical diversity of Gardnerella vaginalisstrains isolated from women with bacterial vaginosis, FEMS Immunol Med Microbiol, 65, 69, 10.1111/j.1574-695X.2012.00940.x Hardy, 2017, The presence of the putative Gardenerella vaginalis sialidase A gene in vaginal specimens is associated with bacterial vaginosis biofilm, PLoS One, 12, 10.1371/journal.pone.0172522 Briselden, 1992, Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora, J Clin Microbiol, 30, 663, 10.1128/jcm.30.3.663-666.1992 Swidsinski, 2013, Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis, PLoS One, 8, 10.1371/journal.pone.0053997 Onywera, 2020, The penile microbiota in uncircumcised and circumcised men: relationships with HIV and Human papillomavirus infections and cervicovaginal microbiota, Front Med (Lausanne), 7, 383, 10.3389/fmed.2020.00383 Zozaya, 2016, Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis, Microbiome, 4, 16, 10.1186/s40168-016-0161-6 Eren, 2011, Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation, PLoS One, 6, 10.1371/journal.pone.0026732 Plummer, 2018, Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: acceptability, tolerability and impact on the genital microbiota of couples - a pilot study, PLoS One, 13, 10.1371/journal.pone.0190199 Kenyon, 2019, Differential sexual network connectivity offers a parsimonious explanation for population-level variations in the prevalence of bacterial vaginosis: a data-driven, model-supported hypothesis, BMC Wom Health, 19, 8, 10.1186/s12905-018-0703-0 Liu, 2015, Penile microbiota and female partner bacterial vaginosis in Rakai, Uganda, mBio, 6, 10.1128/mBio.00589-15 Klebanoff, 2010, Race of male sex partners and occurrence of bacterial vaginosis, Sex Transm Dis, 37, 184, 10.1097/OLQ.0b013e3181c04865 Carda-Diéguez, 2019, Variations in vaginal, penile, and oral microbiota after sexual intercourse: a case report, Front Med (Lausanne), 6, 178, 10.3389/fmed.2019.00178 Fethers, 2008, Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis, Clin Infect Dis, 47, 1426, 10.1086/592974 Kenyon, 2017, Strong associations between national prevalence of various STIs suggests sexual network connectivity is a common underpinning risk factor, BMC Infect Dis, 17, 682, 10.1186/s12879-017-2794-x Herati, 2018, Penile prosthesis biofilm formation and emerging therapies against them, Transl Androl Urol, 7, 960, 10.21037/tau.2018.09.05 Mehta, 2020, The microbiome composition of a man's penis predicts incident Bacterial vaginosis in his female sex partner with high accuracy, Front Cell Infect Microbiol, 10, 433, 10.3389/fcimb.2020.00433 Schwebke, 2021, Treatment of male sexual partners of women with Bacterial vaginosis: a randomized, double-blind, placebo-controlled trial, Clin Infect Dis, 73, e672, 10.1093/cid/ciaa1903 Kalra, 2007, Bacterial vaginosis: culture-and PCR-based characterizations of a complex polymicrobial disease's pathobiology, Curr Infect Dis Rep, 9, 485, 10.1007/s11908-007-0074-4 Brotman, 2010, Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection, J Infect Dis, 202, 1907, 10.1086/657320 Udayalaxmi, 2011, Comparison of the methods of diagnosis of bacterial vaginosis, J Clin Diagn Res, 5, 498 Hainer, 2011, Vaginitis: diagnosis and treatment, Am Fam Physician, 83, 807 Money, 2005, The laboratory diagnosis of bacterial vaginosis, Can J Infect Dis Med Microbiol, 16, 77, 10.1155/2005/230319 Nugent, 1991, Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation, J Clin Microbiol, 29, 297, 10.1128/jcm.29.2.297-301.1991 Moussavi, 2004, Diagnostic Amsel criteria compared standardized method of Gram stain for the diagnosis of bacterial vaginosis, Int Congr Ser, 1271, 392, 10.1016/j.ics.2004.05.094 Bradshaw, 2005, Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis, J Clin Microbiol, 43, 1304, 10.1128/JCM.43.3.1304-1308.2005 Bhujel, 2021, Comparative study of Amsel's criteria and Nugent scoring for diagnosis of bacterial vaginosis in a tertiary care hospital, Nepal, BMC Infect Dis, 21, 825, 10.1186/s12879-021-06562-1 Bansal, 2019, Comparison of Amsel's criteria and Nugent's criteria for diagnosis of bacterial vaginosis in tertiary care centre, Int J Reprod Contracept Obstet Gynecol, 8, 637, 10.18203/2320-1770.ijrcog20190297 Mengistie, 2013, Comparison of clinical and gram stain diagnosis methods of bacterial vaginosis among pregnant women in Ethiopia, J Clin Diagn Res, 7, 2701 Hossien, 2015, Evaluation and comparison between Amsel's Criteria and Nugent's score methods in diagnosis of bacterial vaginosis in non-pregnant women, J Sci Res Rep, 5, 500 Mohammadzadeh, 2014, Diagnostic value of Amsel's clinical criteria for diagnosis of bacterial vaginosis, Global J Health Sci, 7, 8, 10.5539/gjhs.v7n3p8 Sha, 2005, Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis and Lactobacillusspp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women, J Clin Micrbiol, 43, 4607, 10.1128/JCM.43.9.4607-4612.2005 Mittal, 2012, Development of modified diagnostic criteria for bacterial vaginosis at peripheral health centres in developing countries, J Infect Dev Ctries, 6, 373, 10.3855/jidc.1625 Ison, 2002, Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics, Sex Transm Infect, 78, 413, 10.1136/sti.78.6.413 Antonucci, 2017, Comparison between Nugent's and Hay/Ison scoring criteria for the diagnosis of bacterial vaginosis in WASP prepared vaginal samples, Clin Invest, 7, 89, 10.4172/Clinical-Investigation.1000116 Chawla, 2013, Comparison of Hay's criteria with Nugent's scoring system for diagnosis of bacterial vaginosis, BioMed Res Int, 2013, 10.1155/2013/365194 Redelinghuys, 2020, Bacterial vaginosis: current diagnostic avenues and future opportunities, Front Cell Infect Microbiol, 10, 354, 10.3389/fcimb.2020.00354 Blankenstein, 2015, Point-of-care (POC) diagnosis of bacterial vaginosis (BV) using VGTestTM ion mobility spectrometry (IMS) in a routine ambulatory care gynecology clinic, Arch Gynecol Obstet, 292, 355, 10.1007/s00404-014-3613-x Myziuk, 2003, BVBlue test for diagnosis of bacterial vaginosis, J Clin Microbiol, 41, 1925, 10.1128/JCM.41.5.1925-1928.2003 West, 2003, Evaluation of a new rapid diagnostic kit (FemExam) for bacterial vaginosis in patients with vaginal discharge syndrome in the Gambia, Sex Transm Dis, 30, 483, 10.1097/00007435-200306000-00003 Lynch, 2019, Molecular diagnosis of vaginitis: comparing quantitative PCR and microbiome profiling approaches to current microscopy scoring, J Clin Microbiol, 57, e00300, 10.1128/JCM.00300-19 Janulaitiene, 2017, Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis, BMC Infect Dis, 17, 394, 10.1186/s12879-017-2501-y 2021, Centers for disease control and Prevention．Sexually transmitted diseases treatment guidelines, MMWR, 70, 82 Dols, 2011, Microarray-based identification of clinically relevant vaginal bacteria in relation to bacterial vaginosis, Am J Obstet Gynecol, 204, 305.e1, 10.1016/j.ajog.2010.11.012 Hong, 2016, Analysis of the vaginal microbiome by next-generation sequencing and evaluation of its performance as a clinical diagnostic tool in vaginitis, Ann Lab Med, 36, 441, 10.3343/alm.2016.36.5.441 Budd, 2015, Metagenomics analysis using next generation sequencing of vaginal samples from community practices in the US, MOJ Cell Sci Rep, 2, 16 Mayer, 2015, Rapid and profound shifts in the vaginal microbiota following antibiotic treatment for bacterial vaginosis, J Infect Dis, 212, 793, 10.1093/infdis/jiv079 Mullany, 2014, Functional metagenomics for the investigation of antibiotic resistance, Virulence, 5, 443, 10.4161/viru.28196 Peters, 2019, Metaproteomic and metabolomic approaches for characterizing the gut microbiome, Proteomics, 19, 10.1002/pmic.201800363 Ferreira, 2018, Protein content of cervicovaginal fluid is altered during bacterial vaginosis, J Low Genit Tract, 22, 147, 10.1097/LGT.0000000000000367 Parolin, 2018, Insights into vaginal bacterial communities and metabolic profiles of Chlamydia trachomatis infection: positioning between eubiosis and dysbiosis, Front Microbiol, 9, 600, 10.3389/fmicb.2018.00600 Mlisana, 2012, Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa, J Infect Dis, 206, 6, 10.1093/infdis/jis298 Thurman, 2015, Bacterial vaginosis and subclinical markers of genital tract inflammation and mucosal immunity, AIDS Res Hum Retrovir, 31, 1139, 10.1089/aid.2015.0006 Kunze, 2016, Cytokines in noninvasively obtained amniotic fluid as predictors of fetal inflammatory response syndrome, Am J Obstet Gynecol, 215, e1 Beck, 2015, Machine learning classifiers provide insight into the relationship between microbial communities and bacterial vaginosis, BioData Min, 8, 23, 10.1186/s13040-015-0055-3 Song, 2017, Segmentation, splitting, and classification of overlapping bacteria in microscope images for automatic bacterial vaginosis diagnosis, IEEE J Biomed Health Inform, 21, 1095, 10.1109/JBHI.2016.2594239 Beck, 2014, Machine learning techniques accurately classify microbial communities by bacterial vaginosis characteristics, PLoS One, 9, 10.1371/journal.pone.0087830 Muzny, 2022, Diagnosis and management of bacterial vaginosis: summary of evidence reviewed for the 2021 centers for disease control and prevention sexually transmitted infections treatment guidelines, Clin Infect Dis, 74, S144, 10.1093/cid/ciac021 Allsworth, 2011, Severity of bacterial vaginosis and the risk of sexually transmitted infection, Am J Obstet Gynecol, 205, 113.e1, 10.1016/j.ajog.2011.02.060 Wiesenfeld, 2003, Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection, Clin Infect Dis, 36, 663, 10.1086/367658 Abbai, 2016, Prevalent bacterial vaginosis infection- a risk factor for incident sexually transmitted infections in women in Durban, South Africa, Int J STD AIDS, 27, 1283, 10.1177/0956462415616038 Bautista, 2017, Association of bacterial vaginosis with chlamydia and gonorrhea among women in the U.S. Army, Am J Prev Med, 52, 632, 10.1016/j.amepre.2016.09.016 Cherpes, 2003, Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis, Clin Infect Dis, 37, 319, 10.1086/375819 Cherpes, 2008, A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive Herpes Simplex Virus type 2 serology, Sex Transm Dis, 35, 78, 10.1097/OLQ.0b013e318156a5d0 Abbai, 2018, Prevalent Herpes Simplex Virus-2 increases the risk of incident bacterial vaginosis in women from South Africa, AIDS Behav, 22, 2172, 10.1007/s10461-017-1924-1 Armstrong, 2021, Beyond bacterial vaginosis: vaginal lactobacilli and HIV risk, Microbiome, 9, 239, 10.1186/s40168-021-01183-x Cohen, 2016, Vaginal microbiome affects HIV risk, Science, 353, 331, 10.1126/science.353.6297.331 Gosmann, 2017, Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women, Immunity, 46, 29, 10.1016/j.immuni.2016.12.013 Di Paola, 2017, Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection, Sci Rep, 7, 10.1038/s41598-017-09842-6 Lee, 2013, Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort, PLoS One, 8 Cheng, 2020, Vaginal microbiota and human papillomavirus infection among young Swedish women, NPJ Biofilms Microbiomes, 6, 39, 10.1038/s41522-020-00146-8 Haggerty, 2020, Presence and concentrations of select bacterial vaginosis-associated bacteria are associated with increased risk of pelvic inflammatory disease, Sex Transm Dis, 47, 344, 10.1097/OLQ.0000000000001164 Turpin, 2021, Bacterial vaginosis and behavioral factors associated with incident pelvic inflammatory disease in the longitudinal study of vaginal flora, J Infect Dis, 224, S137, 10.1093/infdis/jiab103 Fettweis, 2019, The vaginal microbiome and preterm birth, Nat Med, 25, 1012, 10.1038/s41591-019-0450-2 Koumans, 2002, Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data, Clin Infect Dis, 35, S152, 10.1086/342103 Davies, 2006, Where have all the antibiotics gone?, Can J Infect Dis Med Microbiol, 17, 287, 10.1155/2006/707296 Menard, 2011, Antibacterial treatment of bacterial vaginosis: current and emerging therapies, Int J Womens Health, 3, 295, 10.2147/IJWH.S23814 Workowski, 2015, Sexually transmitted diseases treatment guidelines, MMWR Recomm Rep, 64, 1 Oduyebo, 2009, The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women, Cochrane Database Syst Rev, 8, CD006055 Bradshaw, 2016, Current treatment of bacterial vaginosis- Limitations and need for innovation, J Infect Dis, 214, 14, 10.1093/infdis/jiw159 Zhou, 2004, Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods, Microbiology (Reading), 150, 2565, 10.1099/mic.0.26905-0 Ventola, 2015, The antibiotic resistance crisis, Pharm Therapeut, 40, 277 Rigo, 2020, Vaginitis: review on drug resistance, Curr Drug Targets, 21, 1672, 10.2174/1389450121666200804112340 Tumuhamye, 2021, Vaginal colonization with antimicrobial-resistant bacteria among women in labor in central Uganda: prevalence and associated factors, Antimicrob Resist Infect Control, 10, 37, 10.1186/s13756-021-00897-9 Bradshaw, 2006, Fairley, High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence, J Infect Dis, 193, 1478, 10.1086/503780 Nagaraja, 2008, Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis, Indian J Med Microbiol, 26, 155 Shaskolskiy, 2016, Drug resistance mechanisms in bacteria causing sexually transmitted diseases and associated with vaginosis, Front Microbiol, 7, 747, 10.3389/fmicb.2016.00747 Bahar, 2005, Mobiluncus species in gynaecological and obstetric infections: antimicrobial resistance and prevalence in a Turkish population, Int J Antimicrob Agents, 25, 268, 10.1016/j.ijantimicag.2004.09.019 Srinivasan, 2008, The human vaginal bacterial biota and bacterial vaginosis, Interdiscip Perspect Infect Dis, 2008, 10.1155/2008/750479 Srinivasan, 2013, O05.3 more than meets the eye: a molecular phylogenetic analysis reveals importance of novel bacteria in bacterial vaginosis (BV), J Sex Transm Dis, 89 Gao, 2022, High-throughput sequencing-based analysis of changes in the vaginal microbiome during the disease course of patients with bacterial vaginosis: a case control-study, Biology (Basel), 11, 1797 Schuyler, 2015, Draft genome sequence of a metronidazole-resistant derivative of Gardnerella vaginalis strain ATCC 14019, Genome Announc, 3 Dhand, 2009, Mechanism of resistance in metronidazole, 223 Löfmark, 2010, Metronidazole is still the drug of choice for treatment of anaerobic infections, Clin Infect Dis, 50, 16, 10.1086/647939 De Backer, 2006, Antibiotic susceptibility of Atopobium vaginae, BMC Infect Dis, 16, 51, 10.1186/1471-2334-6-51 Van, 2007, Antibiotic resistance in food-borne bacterial contaminants in Vietnam, Appl Environ Microbiol, 73, 7906, 10.1128/AEM.00973-07 Javed, 2019, Bacterial vaginosis: an insight into the prevalence, alternative treatments regimen and it's associated resistance patterns, Microb Pathog, 127, 21, 10.1016/j.micpath.2018.11.046 Aguin, 2014, High-dose vaginal maintenance metronidazole for recurrent bacterial vaginosis: a pilot study, Sex Transm Dis, 41, 290, 10.1097/OLQ.0000000000000123 Hardy, 2016, A fruitful alliance: the synergy between Atopobium vaginae and Gardnerella vaginalis in bacterial vaginosis-associated biofilm, Sex Transm Infect, 92, 487, 10.1136/sextrans-2015-052475 Faught, 2019, Characterization and treatment of recurrent bacterial vaginosis, J Womens Health (Larchmt), 28, 1218, 10.1089/jwh.2018.7383 Swidsinski, 2008, An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole, Am J Obstet Gynecol, 198, e1 Ahrens, 2020, Changes in the vaginal microbiota following antibiotic treatment for Mycoplasma genitalium, Chlamydia trachomatis and bacterial vaginosis, PLoS One, 15, 10.1371/journal.pone.0236036 Reichman, 2009, Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis, Sex Transm Dis, 36, 732, 10.1097/OLQ.0b013e3181b08456 Hymes, 2013, DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo, J Infect Dis, 207, 1491, 10.1093/infdis/jit047 Thellin, 2016, Lysozyme as a cotreatment during antibiotics use against vaginal infections: an in vitro study on Gardnerella vaginalis biofilm models, Int Microbiol, 19, 101 Gottschick, 2016, Screening of compounds against Gardnerella vaginalis biofilms, PLoS One, 11, 10.1371/journal.pone.0154086 Gottschick, 2017, Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis, Microbiome, 5, 119, 10.1186/s40168-017-0326-y Turovskiy, 2012, Susceptibility of Gardnerella vaginalis biofilms to natural antimicrobials subtilosin, ε-poly-L-lysine, and lauramide arginine ethyl ester, Infect Dis Obstet Gynecol, 2012, 10.1155/2012/284762 Eade, 2013, The anti-HIV microbicide candidate RC-101 inhibits pathogenic vaginal bacteria without harming endogenous flora or mucosa, Am J Reprod Immunol, 69, 150, 10.1111/aji.12036 Saunders, 2007, Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms, Colloids Surf B Biointerfaces, 55, 138, 10.1016/j.colsurfb.2006.11.040 Braga, 2010, Inhibitory activity of thymol on native and mature Gardnerella vaginalis biofilms: in vitro study, Arzneimittelforschung, 60, 675 Swidsinski, 2015, Polymicrobial Gardnerella biofilm resists repeated intravaginal antiseptic treatment in a subset of women with bacterial vaginosis: a preliminary report, Arch Gynecol Obstet, 291, 605, 10.1007/s00404-014-3484-1 Weeks, 2019, Cationic amphiphiles against Gardnerella vaginalis resistant strains and bacterial vaginosis-associated pathogens, Pathog Dis, 77, ftz059, 10.1093/femspd/ftz059 Landlinger, 2021, Engineered phage endolysin eliminates Gardnerella biofilm without damaging beneficial bacteria in bacterial vaginosis ex vivo, Pathogens, 10, 54, 10.3390/pathogens10010054 Coste, 2012, Safety and efficacy of an intravaginal prebiotic gel in the prevention of recurrent bacterial vaginosis: a randomized double-blind study, Obstet Gynecol Int, 2012, 10.1155/2012/147867 Marrazzo, 2013, Bacterial vaginosis, 463 Park, 2023, Efficacy and Safety of MED-01 Probiotics on vaginal health: a 12-week, multicenter, randomized, double-blind, placebo-controlled clinical trial, Nutrients, 331, 10.3390/nu15020331 Bohbot, 2018, Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence, J Gynecol Obstet Hum Reprod, 47, 81, 10.1016/j.jogoh.2017.11.005 Tomusiak, 2015, Efficacy and safety of a vaginal medicinal product containing three strains of probiotic bacteria: a multicenter, randomized, double-blind, and placebo-controlled trial, Drug Des Dev Ther, 9, 5345, 10.2147/DDDT.S89214 Ma, 2019, Vaginal microbiota transplantation for the treatment of bacterial vaginosis: a conceptual analysis, FEMS Microbiol Lett, 366, fnz025, 10.1093/femsle/fnz025 Lev-Sagie, 2019, Vaginal microbiome transplantation in women with intractable bacterial vaginosis, Nat Med, 25, 1500, 10.1038/s41591-019-0600-6 Schwebke, 2017, A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2g for the treatment of women with bacterial vaginosis, Am J Obstet Gynecol, 217, e1 Cohen, 2020, Randomized trial of Lactin-V to prevent recurrence of bacterial vaginosis, N Engl J Med, 382, 1906, 10.1056/NEJMoa1915254 Subtil, 2018, Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomized controlled trial, Lancet, 392, 2171, 10.1016/S0140-6736(18)31617-9 Russo, 2019, Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial, Benef Microbes, 10, 19, 10.3920/BM2018.0075 Laue, 2018, Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women – a double-blind, randomised, controlled clinical pilot trial, Benef Microbes, 9, 35, 10.3920/BM2017.0018 Hillier, 2017, Secnidazole treatment of bacterial vaginosis: a randomized controlled trial, Obstet Gynecol, 130, 379, 10.1097/AOG.0000000000002135 Latham-Cork, 2021, A novel non-antimicrobial treatment of bacterial vaginosis: an open label two-private centre study, Eur J Obstet Gynecol Reprod Biol, 256, 419, 10.1016/j.ejogrb.2020.11.059 Recine, 2016, Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case- control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis, Arch Gynecol Obstet, 293, 101, 10.1007/s00404-015-3810-2 Vicariotto, 2014, Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study, J Clin Gatroenterol, 48, 106, 10.1097/MCG.0000000000000226 Husain, 2020, Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis, BJOG, 127, 275, 10.1111/1471-0528.15675 Waldbaum, 2020, A phase 2, double-blind, multicentre, randomized, placebo-controlled, dose-ranging study of the efficacy and safety of Astodrimer gel for the treatment of bacterial vaginosis, PLoS One, 15, 10.1371/journal.pone.0232394 Schwebke, 2021, A phase 3, randomized, controlled trial of Astodrimer 1% gel for preventing recurrent bacterial vaginosis, Eur J Obstet Gynecol Reprod Biol X, 10, 10.1016/j.eurox.2021.100121 Chavoustie, 2019, Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% gel for the treatment of bacterial vaginosis, Eur J Obstet Gynecol Reprod Biol, 245, 13, 10.1016/j.ejogrb.2019.11.032 Schwebke, 2015, A phase 3, multicentre, randomized, double-blind, vehicle-controlled study evaluating the safety and efficacy of metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis, Sex Transm Dis, 42, 376, 10.1097/OLQ.0000000000000300 Plummer, 2021, A prospective, open- label pilot study of concurrent male partner treatment for bacterial vaginosis, mBio, 12, 10.1128/mBio.02323-21 Raja, 2016, Randomized, double-blind, comparative study of oral metronidazole and tinidazole in treatment of bacterial vaginosis, Indian J Pharmacol, 48, 654, 10.4103/0253-7613.194843 Elsharkawy, 2021, Continuous versus interrupted use of vaginal probiotics plus vaginal clindamycin cream for bacterial vaginosis: a randomized controlled study, J Matern Fetal Neonatal Med, 34, 58, 10.1080/14767058.2019.1588246 Badawi, 2021, Clinical comparative study of optimized metronidazole loaded lipid nanocarrier vaginal emulgel management of bacterial vaginosis and its recurrence, Drug Deliv, 28, 814, 10.1080/10717544.2021.1912211 Pentikis, 2020, An integrated efficacy and safety analysis of single-dose secnidazole 2g in the treatment of bacterial vaginosis, Reprod Sci, 27, 523, 10.1007/s43032-019-00048-x Nava-Memije, 2021, Bacterial vaginosis and sexually transmitted infections in an HIV-positive cohort, Front Reprod Health, 3, 10.3389/frph.2021.660672 Torrone, 2018, Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: an individual participant data meta-analysis of 18 HIV prevention studies, PLoS Med, 15 Singh, 2014, Current socioclinical trend of sexually transmitted diseases and relevance of STD clinic: a comparative study from referral tertiary care center of Gwalior, India, Drug Development and Therapeutics, 5, 134, 10.4103/2394-2002.139627 Chauhan, 2014, Sexually transmitted infections in women: a correlation of clinical and laboratory diagnosis in cases of vaginal discharge syndrome, Indian Dermatol Online J, 5, 1, 10.4103/2229-5178.144498 Jespers, 2014, Prevalence and correlates of Bacterial Vaginosis in different sub-populations of women in sub-Saharan Africa: a cross-sectional study, PLoS One, 9, 10.1371/journal.pone.0109670 Das, 2011, Prevalence and assessment of clinical management of Sexually Transmitted Infections among female sex workers in two cities of India, Infect Dis Obstet Gynecol, 2011, 10.1155/2011/494769 Madhivanan, 2008, Prevalence and correlates of bacterial vaginosis among young women of reproductive age in Mysore, India, Indian J Med Microbiol, 26, 132, 10.1016/S0255-0857(21)01928-9